Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “intervention”

12 pharma patents match "intervention" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "intervention" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “intervention” · 30,257 patents in full index Clear search

  1. US 10874748

    Intervention for tendinopathy

    Montefiore Medical Center · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  2. US 10525106

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  3. US 10251938

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted
  4. US 9968653

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  5. US 9639665

    Methods for diagnosis and intervention of hepatic disorders

    The Regents of the University of Colorado, a Body Corporate · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  6. US 9592271

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  7. US 9457070

    Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted
  8. US 8613904

    Methods for diagnosis and intervention of hepatic disorders

    The Regents of the University of Colorado · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted
  9. US 8403844

    Methods for interventions

    BioMarker Pharmaceuticals, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  10. US 6756408

    Methods and materials for protecting against myocardial cell damage related to coronary intervention by regional beta blocker therapy

    The Board of Regents of the University of Texas System · Granted Jun 29, 2004 · Expires Jun 24, 2024

    expired
  11. US 6756399

    Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2004 · Expires Jun 24, 2024

    expired
  12. US 6071949

    Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 6, 2000 · Expires Jun 1, 2020

    expired